Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury
CA 2312867 A1 · Owner: Neely, Constance F. · Inventors: Neely, Constance F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of preventing or treating ischemia-reperfusion injury in an organ by administration of a composition containing a selective A1 adenosine receptor antagonist and/or a P2X purinoceptor antagonist are provided. Methods of preventing or treating endotoxin-related tissue injury by administration of a composition containing a selective A1 adenosine receptor antagonist and/or a P2X purinoceptor antagonist are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 23, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 23, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 23, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.